2015
Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter study
Abstract: These findings further support the diagnostic value of intrathecal KFLC synthesis in CIS and MS patients and demonstrate a valid, easier and rater-independent alternative to OCB detection.
Search citation statements
Paper Sections
Select...
93
23
21
6
Citation Types
8
116
0
1
Year Published
Range
2000
2026
Publication Types
Select...
113
10
2
1
Relationship
9
117
Authors
Journals
Cited by 126 publications
(125 citation statements)
References 33 publications
8
116
0
1
CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort
Front. Immunol.
Self Cite
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…In line with previous studies from others and us (17, 18, 26) the present study confirms elevated intrathecal KFLC and LFLC production in patients with MS leading to high diagnostic accuracy. To allow an assessment of the utility and strengths of different FLC measures, we determined not only CSF and serum levels of FLC but also compared various FLC measures including CSF-serum ratio (Q KFLC, Q LFLC), FLC index (KFLC index, LFLC index), and CSF KFLC to LFLC ratio within one large cohort for their diagnostic accuracy in MS.…”
Section: Discussion
supporting
confidence: 93%